Get the latest news on Infinity Pharmaceuticals stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on INFIQ performance

Latest Infinity Pharmaceuticals Stock News | OTC:INFIQ | Benzinga

Infinity Pharmaceuticals Inc is a clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. The company's developed products and those under development include therapies targeting hematologic malignancies, or blood cancers; refractory indolent non-Hodgkin lymphoma; refractory chronic lymphocytic leukemia; and solid tumors, including melanoma and non-small cell lung cancer. Infinity has a strategic partnership with AbbVie to develop some of its oncology related treatments. The company operates in only one segment which is drug development.

INFINITY PHARMS INC by Infinity Pharmaceuticals, Inc.

Comments

Infinity Pharmaceuticals Stock News

News

Latest Infinity Pharmaceuticals Stock News | OTC:INFIQ | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga